Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study-Reference-Cited by-同舟云学术

Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study

Published:2014-05 Issue:6 Volume:15 Page:592-600
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Tombal Bertrand,Borre Michael,Rathenborg Per,Werbrouck Patrick,Van Poppel Hendrik,Heidenreich Axel,Iversen Peter,Braeckman Johan,Heracek Jiri,Baskin-Bey Edwina,Ouatas Taoufik,Perabo Frank,Phung De,Hirmand Mohammad,Smith Matthew R

Funder

National Institute of Health K24 Midcareer Investigator Award

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Guidelines on prostate cancer;Heidenreich,2013

2. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer;DiBlasio;BJU Int,2008

3. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer;Taylor;Cancer,2009

4. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study;Jespersen;Eur Urol,2014

5. Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer;Verhelst;Clin Endocrinol (Oxf),1994

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale;Clinical Genitourinary Cancer;2024-12

2. Inhibitors of the transactivation domain of androgen receptor as a therapy for prostate cancer;Steroids;2024-10

3. Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer;Molecular Diversity;2024-04-20

4. Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials;Prostate Cancer and Prostatic Diseases;2024-04-08

5. Hormone Therapy for Advanced Prostate Cancer;Prostate Cancer;2024